Pancreatic Cancer Research

ResearcherThe University of MelbourneNo recent work listed

Clare Y. Slaney

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6986-6115; OpenAlex author ID A5087180556. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer. Last author DOI 10.1158/1078-0432.ccr-21-1141↗
  2. Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment. Co-author DOI 10.1002/cti2.1165↗
  3. Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer. Last author DOI 10.3389/fonc.2019.00056↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aesha I. Ali · 2 shared papers, 2019–2021 · strength 0.22
  2. Belinda Lee · 1 shared paper, 2021 · strength 0.11
  3. Delphine Quatannens · 1 shared paper, 2020 · strength 0.09
  4. Jinthe Van Loenhout · 1 shared paper, 2020 · strength 0.09
  5. Evelien Smits · 1 shared paper, 2020 · strength 0.09
  6. Jonas R.M. Van Audenaerde · 1 shared paper, 2020 · strength 0.09
  7. Geert Roeyen · 1 shared paper, 2020 · strength 0.09
  8. Marc Peeters · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.